# Cortagen

> Cortagen is a short synthetic peptide belonging to a family of so-called peptide bioregulators developed in Russia, intended to support function of the cerebral cortex. It is described within that research tradition as a tissue-specific regulator theorized to help maintain normal gene expression patterns in cortical neurons, particularly in the context of aging. Published research is dominated by studies from the originating research group, with limited independent replication in Western literature, so its profile should be regarded as an emerging area of study rather than an established finding. It is not approved for medical use and is available only as a research compound.

- URL: https://www.lifeconverted.com/peptides/cortagen
- Primary category: Cognitive & Neuro
- Effectiveness rank: #11 in Cognitive & Neuro
- Evidence level: Emerging research
- Route: Subcutaneous (Administered by subcutaneous injection in research contexts; oral capsule forms have also been described in the originating bioregulator literature.)
- Dose range: 1-3 mg
- Dose tiers: low 1 mg; moderate 2 mg; high 3 mg
- Half-life: Specific pharmacokinetic data are not well characterized in independent literature; as a short peptide it is presumed to be cleared rapidly, within a period of minutes to a few hours.
- Timing: Morning
- Cycle: 10-20 days on, 3-6 months off (Bioregulator protocols described in the originating literature typically use short intensive courses followed by long breaks, unlike the more continuous schedules used for other peptides.)
- Storage: Store lyophilized peptide refrigerated or frozen prior to reconstitution, protected from light; refrigerate reconstituted solution and use within a few weeks.

## Mechanism of action

Cortagen is proposed to act as a short regulatory peptide capable of interacting with chromatin to influence gene transcription in cortical tissue, a mechanism described within the broader peptide bioregulator theory of tissue-specific aging modulation. This proposed mechanism has not been independently validated using contemporary molecular techniques outside the originating research program.

## Reported benefits

- Proposed support for cortical neuron function in aging-related research
- Explored within bioregulator theory as a tool for studying cognitive aging
- Investigated for potential neuroprotective properties in preclinical models
- Discussed as a component of broader longevity-focused research protocols

## Reported side effects

- Very limited independent human safety data
- Injection site irritation with subcutaneous use
- Unknown long-term effects given the small body of independent research
- Mechanism of action not independently confirmed

## Common protocols

- Short intensive courses of 10-20 days followed by extended breaks, consistent with the bioregulator research tradition

## Stacking notes

Often discussed alongside other bioregulator peptides such as Pinealon within longevity-focused research protocols; no controlled data exist on combined use.

---

Educational information only, not medical advice. Full disclaimer: https://www.lifeconverted.com/disclaimer